Centerpoint Advisors’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$0 Hold
100
﹤0.01% 412
2026
Q1
$0 Hold
100
﹤0.01% 407
2025
Q4
$0 Hold
100
﹤0.01% 430
2025
Q3
$1K Hold
100
﹤0.01% 426
2025
Q2
$1K Hold
100
﹤0.01% 366
2025
Q1
$1K Sell
100
-100
-50% -$567 ﹤0.01% 374
2024
Q4
$1K Hold
200
﹤0.01% 430
2024
Q3
$1K Sell
200
-200
-50% -$1.15K ﹤0.01% 452
2024
Q2
$3K Hold
400
﹤0.01% 396
2024
Q1
$4K Sell
400
-100
-20% -$739 ﹤0.01% 371
2023
Q4
$4K Hold
500
﹤0.01% 369
2023
Q3
$3K Hold
500
﹤0.01% 423
2023
Q2
$2K Buy
500
+200
+67% +$444 ﹤0.01% 447
2023
Q1
$1K Hold
300
﹤0.01% 507
2022
Q4
$1K Hold
300
﹤0.01% 450
2022
Q3
$1K Hold
300
﹤0.01% 356
2022
Q2
$1K Hold
300
﹤0.01% 360
2022
Q1
$1K Hold
300
﹤0.01% 366
2021
Q4
$1K Sell
300
-200
-40% -$945 ﹤0.01% 381
2021
Q3
$3K Buy
500
+200
+67% +$1.71K ﹤0.01% 241
2021
Q2
$4K Hold
300
﹤0.01% 238
2021
Q1
$5K Buy
300
+100
+50% +$1.8K ﹤0.01% 206
2020
Q4
$1K Buy
+200
New +$1.47K ﹤0.01% 235

Other funds holding LFMD

Centerpoint Advisors's LFMD Position: Q2 2026 in Review

Centerpoint Advisors held its LifeMD (LFMD) position steady in Q2 2026 at 100 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #412.

Centerpoint Advisors first reported a position in LFMD in Q4 2020 and has held it in 23 quarters since. The position peaked at $5K in Q1 2021. 115 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • Centerpoint Advisors held 100 shares of LifeMD worth $0 as of Q2 2026.
  • Centerpoint Advisors left its LifeMD share count unchanged in Q2 2026.
  • LifeMD made up ﹤0.01% of Centerpoint Advisors's portfolio in Q2 2026, its #412 holding.
  • Centerpoint Advisors first reported a position in LifeMD in Q4 2020 and has held it in 23 quarters since.
  • Centerpoint Advisors's LifeMD position peaked at $5K in Q1 2021.
  • 115 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on Centerpoint Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.